HIF1A stabilization restores epigenetic control of Nos1 expression and reverses gastroparesis in female diabetic mice
Fei Gao,Yujiro Hayashi,Siva Arumugam Saravanaperumal,Gabriella B Gajdos,Sabriya A Syed,Aditya V Bhagwate,Zhenqing Ye,Jian Zhong,Yuebo Zhang,Egan L Choi,Sergiy M Kvasha,Jagneet Kaur,Brooke D Paradise,Liang Cheng,Brandon W Simone,Alec M Wright,Todd A Kellogg,Michael L Kendrick,Travis J McKenzie,Zhifu Sun,Huihuang Yan,Chuanhe Yu,Adil E Bharucha,David R Linden,Jeong-Heon Lee,Tamas Ordog,Gabriella B. Gajdos,Sabriya A. Syed,Aditya V. Bhagwate,Egan L. Choi,Sergiy M. Kvasha,Brooke D. Paradise,Brandon W. Simone,Alec M. Wright,Todd A. Kellogg,Michael L. Kendrick,Travis J. McKenzie,Adil E. Bharucha,David R. Linden
DOI: https://doi.org/10.1053/j.gastro.2023.08.009
IF: 29.4
2023-08-20
Gastroenterology
Abstract:Background and Aims While depletion of neuronal nitric oxide synthase ( NOS1 )-expressing neurons contributes to gastroparesis, stimulating nitrergic signaling is not an effective therapy. We investigated whether hypoxia-inducible factor 1α (HIF1A), which is activated by high O 2 consumption in central neurons, is a Nos1 transcription factor in enteric neurons and whether stabilizing HIF1A reverses gastroparesis. Methods Streptozotocin-diabetic mice, human and mouse tissues, NOS1 + mouse neuroblastoma cells, and isolated nitrergic neurons were studied. Gastric emptying of solids and volumes were determined by breath test and single-photon emission computed tomography, respectively. Gene expression was analyzed by RNA-sequencing, microarrays, immunoblotting, and immunofluorescence. Epigenetic assays included chromatin immunoprecipitation-sequencing (13 targets), chromosome conformation capture-sequencing, and reporter assays. Mechanistic studies utilized Cre-mediated recombination, RNA interference, and CRISPR-Cas9-mediated epigenome editing. Results HIF1A signaling from physiological intracellular hypoxia was active in mouse and human NOS1 + myenteric neurons but reduced in diabetes. Deleting Hif1a in Nos1 -expressing neurons reduced NOS1 protein by 50-92% and delayed gastric emptying of solids in female but not male mice. Stabilizing HIF1A with FG-4592/roxadustat, which is approved for human use, restored NOS1 and reversed gastroparesis in female diabetic mice. In nitrergic neurons, HIF1A upregulated Nos1 transcription by binding and activating proximal and distal cis-regulatory elements including newly discovered super-enhancers, facilitating RNA polymerase loading and pause-release, and by recruiting cohesin to loop anchors to alter chromosome topology. Conclusion Pharmacological HIF1A stabilization is a novel, translatable approach to restoring nitrergic signaling and treating diabetic gastroparesis. The newly recognized effects of HIF1A on chromosome topology may provide insights into physioxia- and ischemia-related organ function.
gastroenterology & hepatology